C([Li])CCC.[CH2:6]([CH:8]([C:11]1[N:16]2[N:17]=[C:18]([CH3:28])[C:19]([C:20]3[S:24][C:23]([CH2:25][O:26][CH3:27])=[N:22][CH:21]=3)=[C:15]2[N:14]=[C:13]([CH3:29])[CH:12]=1)[CH2:9][CH3:10])[CH3:7].[Cl:30]N1C(=O)CCC1=O.[Cl-].[NH4+]>C1COCC1>[Cl:30][C:21]1[N:22]=[C:23]([CH2:25][O:26][CH3:27])[S:24][C:20]=1[C:19]1[C:18]([CH3:28])=[N:17][N:16]2[C:11]([CH:8]([CH2:9][CH3:10])[CH2:6][CH3:7])=[CH:12][C:13]([CH3:29])=[N:14][C:15]=12Add n-butyl lithium (2.5 M in hexanes, 174 mL, 0.43 mmol) to a stirred solution of 7-(1-ethyl-propyl)-3-(2-methoxymethyl-thiazol-5-yl)-2,5-dimethyl-pyrazolo[1,5-a]pyrimidine (150 mg, 0.43 mmol) in THF (3 mL) at −78° C. Stir for 30 min and add N-chlorosuccinimide (87 mg, 0.653 mmol). Stir 30 min and then warm the reaction slowly to room temperature allowing the reaction to continue overnight. Quench the reaction by adding saturated ammonium chloride solution, extract with ethyl acetate, dry over sodium sulfate, filter, and concentrate to a residue. Purify by flash chromatography, eluting with hexanes/ethyl acetate (10/2) to give the title compound (7 mg). MS (APCI) m/z (35Cl) 379.3 (M+1)+.
Wird geladen…